These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12826592)

  • 41. Left ventricular filling pressure in sickle cell anemia.
    Norris SL; Johnson C; Haywood LJ
    J Assoc Acad Minor Phys; 1992; 3(1):20-3. PubMed ID: 1576456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 43. Pulmonary complications of sickle cell disease.
    Khoury RA; Musallam KM; Mroueh S; Abboud MR
    Hemoglobin; 2011; 35(5-6):625-35. PubMed ID: 21973051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.
    Morris CR; Gladwin MT; Kato GJ
    Curr Mol Med; 2008 Nov; 8(7):620-32. PubMed ID: 18991648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unloading the right ventricle in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).
    Morrison D; Goldman S; Alepa FP
    Clin Cardiol; 1984 Jan; 7(1):49-53. PubMed ID: 6231150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arginine metabolism, pulmonary hypertension, and sickle cell disease.
    Waugh WH
    JAMA; 2005 Nov; 294(19):2432-3; author reply 2433-4. PubMed ID: 16287948
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications.
    Brampton J; Aaronson PI
    Cardiovasc Hematol Agents Med Chem; 2016; 14(1):4-22. PubMed ID: 26830724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension.
    Landburg PP; Teerlink T; van Beers EJ; Muskiet FA; Kappers-Klunne MC; van Esser JW; Mac Gillavry MR; Biemond BJ; Brandjes DP; Duits AJ; Schnog JJ;
    Haematologica; 2008 Sep; 93(9):1410-2. PubMed ID: 18641026
    [No Abstract]   [Full Text] [Related]  

  • 50. A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.
    Hanson MS; Xu H; Flewelen TC; Holzhauer SL; Retherford D; Jones DW; Frei AC; Pritchard KA; Hillery CA; Hogg N; Wandersee NJ
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H328-36. PubMed ID: 23125208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
    Kato GJ; Gladwin MT; Steinberg MH
    Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sickle cell-spherocytosis associated with hemolytic anemia.
    DE TORREGROSA MV; ORTIZ A; VARGAS D
    Blood; 1956 Mar; 11(3):260-5. PubMed ID: 13293202
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.
    Machado RF; Gladwin MT
    Br J Haematol; 2005 May; 129(4):449-64. PubMed ID: 15877728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sickle cell anemia-associated pulmonary arterial hypertension.
    Machado RF
    J Bras Pneumol; 2007; 33(5):583-91. PubMed ID: 18026658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary hypertension and NO in sickle cell.
    Gladwin MT; Barst RJ; Castro OL; Gordeuk VR; Hillery CA; Kato GJ; Kim-Shapiro DB; Machado R; Morris CR; Steinberg MH; Vichinsky EP
    Blood; 2010 Aug; 116(5):852-4. PubMed ID: 20688967
    [No Abstract]   [Full Text] [Related]  

  • 56. Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.
    Machado RF; Farber HW
    Clin Chest Med; 2013 Dec; 34(4):739-52. PubMed ID: 24267302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective nitric oxide metabolism in sickle cell disease.
    Kato GJ
    Pediatr Blood Cancer; 2015 Mar; 62(3):373-4. PubMed ID: 25393428
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity".
    Van Beers EJ; Biemond BJ; Schnog JJ;
    Am J Hematol; 2010 Mar; 85(3):217; author reply 217-8. PubMed ID: 20029993
    [No Abstract]   [Full Text] [Related]  

  • 59. Prostaglandin E1 in primary pulmonary hypertension.
    Swan PK; Tibballs J; Duncan AW
    Crit Care Med; 1986 Jan; 14(1):72-3. PubMed ID: 3940758
    [No Abstract]   [Full Text] [Related]  

  • 60. New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy.
    Morris CR
    Treat Respir Med; 2006; 5(1):31-45. PubMed ID: 16409014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.